Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ionis Pharmaceuticals Inc (NASDAQ:IONS)

46.38
Delayed Data
As of 3:59pm ET
 +0.03 / +0.06%
Today’s Change
19.59
Today|||52-Week Range
57.00
-3.03%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues147.3M214.2M283.7M346.6M
 
 
 
 
 
Depreciation And Amortization9.8M9.4M10.2M9.0M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses189.2M252.5M349.2M381.6M
 
 
 
 
 
Research And Development181.6M239.5M319.4M341.8M
 
 
 
 
 
Total Operating Expenses199.0M261.9M359.5M390.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-51.7M-47.7M-75.8M-44.0M
 
 
 
 
 
Extraordinary Charge0.00-8.3M0.00-6.3M
 
 
 
Interest Expense On Debt19.4M22.2M36.7M38.8M
 
 
 
 
 
Other Expenses2.4M21.2M20.3M56.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-66.6M-54.4M-87.9M-83.6M
 
 
 
 
 
Income Taxes-5.9M-15.4M-372.0K-2.9M
 
 
 
 
 
Net Income-60.6M-39.0M-88.3M-86.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS110.5M117.7M119.7M120.9M
 
 
 
 
 
Shares To Calculate EPS Diluted110.5M117.7M119.7M120.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.55-$0.33-$0.74-$0.72
 
 
 
 
 
EPS Diluted-$0.55-$0.33-$0.74-$0.72